Title : BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB.

Pub. Date : 2013 Jan

PMID : 22975686






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-kappaB. Lenalidomide Bruton tyrosine kinase Homo sapiens